Items in normal text – for consideration / items in italics – for information / * indicates additional papers
Drs. I Harris (IH) (Chair) S Hlaing (SH) A Rayani (AR), E Rees (ER), N Shah (NS),
Mrs M Liddell (ML), Executive Officer, Mrs E Harris(EH) (Sec. Assistant)
Drs L El-Sharkawi, Dr J Kletta, H Wilkes
• LMC Executive Committee Meeting on Tuesday 12th June 2018 were ratified by the Committee and signed by the Chairman.
CONSTITUENCY VACANCIES: HW had advised that she would be unable to commit to her role as a member of the Executive team due to family illness. A sabbatical was agreed and she would be welcomed back when circumstances permitted.
No new nominations for LMC membership had been received recently and current vacancies included one in Bridgend, one in Swansea and four in the sessional /first five constituencies.
Bridgend and NPT VTS were currently represented at LMC meetings. The Swansea rep had recently completed training and the course organisers in Swansea would be contacted to nominate a replacement. AR had agreed to speak to new trainees in NPT on 11th September 2018 about the role of the LMC and it was hoped that this would also be arranged for Swansea and Bridgend.
AR / ML
As most of the cluster funding for the financial year was already committed there appeared to be little impetus around developing new projects.
LMC attendance at cluster meetings remained variable with a projected 50% expected to be covered to the end of March 19.
IH provided an update from the meeting on 25th July 2018. The Bowel Screening programme had been discussed and IH had reminded cluster leads that they were not contractually required to act in respect of non-responders and could request that this feed be turned off.
A solution had still not been agreed for practices in NPT. IH advised that it was in the interest of practices/ clusters to find a solution as the Health Board did not have a contractual obligation to continue providing CPD sessions in the absence of clinical cover. ER would discuss with NPT cluster leads.
AR had attended a panel at which a practice closure and the unmanaged dispersal of patients had been proposed prior to Health Board approval. AR would seek clarification of the transitional support arrangements and funding which would be available to practices affected.
AR had attended the meeting on 26th July 2018 at which the ABMU action plan in response to the CHC Access report had been discussed. He had made clear that access was only possible if practices were sustainable and the questionnaire would be redrafted. The access standards would also be redrafted.
A summary of expenditure to 31st July 2018 was tabled and reviewed.
Clarity was required about payment arrangements for GPC Wales officers from April 2019. LMCs in Wales were concerned about the impact on the structure of GPCW and LMCs.
All practices now had access to Datix for Primary Care in which breaches of the standards could be recorded. Data/feedback would be available at the Liaison meeting on 18th September 2018.
The draft minutes had been circulated.
Responses had been submitted by Exec team members.
No details had been received about proposed health developments. AR would seek clarification from the CEO.
A precis of the BMA legal opinion obtained from BMA Law had been shared with ABMU with the expectation that the policy would be reworded to reflect that practices could submit claims retrospectively for a period of up to 6 years.
The draft minutes had been circulated.
AR confirmed that the AHCP (Alternative Health care provider) steering group had agreed to the sharing of information with primary care and a protocol was being written up.
NS confirmed that details of the new AHCP scheme would be released soon. The appeal process would continue to include LMC representation.
IH had contacted 7 practice to encourage them to start the DES as soon as possible as further training would be required if not done by the end of August 2018.
It was unclear why some practices had not taken up the DES when they were already doing the work.
The primary care escalation process was still under discussion.
The proposal for NWIS to act as DPO for Welsh practices was being discussed with GPC Wales on 15th Aug 2018.
The GPDF had forwarded helpful material to ensure LMC compliance with GDPR. ML was actioning the ‘10 point plan’.
No new developments planned at present.
IH had attended a Cwm Taf Liaison meeting on 18th July 2018. Dr Stuart Hackwell, Cwm Taf UHB and Dr Steve Davies, Medical Secy, Bro Taf LMC, would attend the Liaison meeting in OakTree surgery on 18th September 2018.
The closing date for motions was 17th September 2018. The LMC meeting on 11th September 2018 would include a 20 minute ‘Conference motion session’.
14th December 2018: BMA House, London: AR/ML would attend.
Tuesday 19th (pm) and Wednesday 20th March 2019: SH / NS / JD would attend as LMC representatives and AR would attend from GPDF.
SH / NS / JD
NWSSP – Pharmaceuticals Application Committee: The PAC terms of reference included the attendance of a Morgannwg LMC rep at PAC meetings as a non-voting member. Following discussion it was agreed that the decision to attend should be made on a case-by-case basis. Details of new pharmacy applications or relocations would be circulated to cluster leads for comment.
An update paper had been circulated with details of the transition to new GP systems which would commence from January 2019.
• Full LMC Meeting – Tuesday 11th September 2018 – The Mercure Hotel, Swansea
• LMC Executive Committee: 9th October 2018 – venue tbc